Holen Sie sich die Stockscreener-App
11.41
2.14%
-0.25
Handel nachbörslich:
11.41
Schlusskurs vom Vortag:
$11.66
Offen:
$11.64
24-Stunden-Volumen:
2.19M
Relative Volume:
0.82
Marktkapitalisierung:
$1.99B
Einnahmen:
$61.10M
Nettoeinkommen (Verlust:
$-138.36M
KGV:
-8.4519
EPS:
-1.35
Netto-Cashflow:
$-90.59M
1W Leistung:
-1.21%
1M Leistung:
+0.00%
6M Leistung:
+29.66%
1J Leistung:
+9.82%
1-Tages-Spanne:
$11.33
$11.70
1-Wochen-Bereich:
$11.31
$12.10
52-Wochen-Spanne:
$5.80
$13.85
Ocular Therapeutix Inc Stock (OCUL) Company Profile
Firmenname
Ocular Therapeutix Inc
Sektor
Branche
Telefon
781-357-4000
Adresse
15 CROSBY DRIVE, BEDFORD, MA
Vergleichen Sie OCUL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OCUL
Ocular Therapeutix Inc
|
11.41 | 2.47B | 61.10M | -138.36M | -90.59M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Ocular Therapeutix Inc Stock (OCUL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-15 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-04-08 | Eingeleitet | William Blair | Outperform |
| 2025-03-18 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-03-11 | Eingeleitet | Needham | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-06-20 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-05-31 | Fortgesetzt | Piper Sandler | Overweight |
| 2024-02-09 | Eingeleitet | BofA Securities | Buy |
| 2023-04-21 | Eingeleitet | Robert W. Baird | Outperform |
| 2022-08-10 | Fortgesetzt | Berenberg | Buy |
| 2021-08-10 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-12-28 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-12-17 | Eingeleitet | Berenberg | Buy |
| 2020-11-13 | Bestätigt | Raymond James | Strong Buy |
| 2020-08-10 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-03 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-05-21 | Herabstufung | Cowen | Outperform → Market Perform |
| 2019-05-21 | Bestätigt | H.C. Wainwright | Buy |
| 2019-05-21 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2018-12-03 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2018-11-15 | Eingeleitet | Raymond James | Strong Buy |
| 2018-09-07 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-10-24 | Eingeleitet | Guggenheim | Buy |
| 2017-07-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-07-12 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-06-23 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2017-02-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2016-11-15 | Bestätigt | RBC Capital Mkts | Outperform |
| 2016-08-11 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2016-02-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2015-10-23 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2015-08-13 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Ocular Therapeutix Inc Aktie (OCUL) Neueste Nachrichten
Short interest data insights for Ocular Therapeutix Inc.2025 Winners & Losers & Low Risk Investment Opportunities - newser.com
Can Ocular Therapeutix Inc. hit a new high this monthJuly 2025 Institutional & Accurate Technical Buy Alerts - newser.com
Ocular Therapeutix Inc (OCUL) Q3 2025 Earnings Report Preview: What To Expect - GuruFocus
Can Ocular Therapeutix Inc. (0OT) stock beat analyst consensus2025 Dividend Review & Free High Accuracy Swing Entry Alerts - newser.com
Hydrogel-Based Drug Delivery System Market Set to Witness - openPR.com
Will Ocular Therapeutix Inc. stock go up soonInflation Watch & Low Risk High Win Rate Picks - newser.com
What institutional flow reveals about Ocular Therapeutix Inc.Trade Analysis Report & Advanced Technical Signal Analysis - newser.com
Multi asset correlation models including Ocular Therapeutix Inc.Portfolio Risk Summary & Comprehensive Market Scan Reports - newser.com
Why Ocular Therapeutix Inc. stock appeals to analystsJuly 2025 Rallies & Long-Term Investment Growth Plans - newser.com
Why analysts upgrade Ocular Therapeutix Inc. stockEntry Point & Weekly Breakout Opportunity Watchlist - newser.com
Is Ocular Therapeutix Inc. stock undervalued vs historical averagesPortfolio Return Report & Low Volatility Stock Recommendations - newser.com
How to interpret RSI for Ocular Therapeutix Inc. stock2025 Big Picture & Safe Capital Growth Trade Ideas - newser.com
What Ocular Therapeutix (OCUL)'s SOL-1 Trial Milestone and Capital Raise Mean for Shareholders - Sahm
Is Ocular Therapeutix Inc. stock oversold or undervalued2025 Trading Volume Trends & Daily Growth Stock Tips - newser.com
How to recover losses in Ocular Therapeutix Inc. stockJuly 2025 Sector Moves & Community Consensus Trade Alerts - newser.com
Is Ocular Therapeutix Inc. (0OT) stock positioned for digital growth eraWeekly Trade Recap & Daily Risk Controlled Trade Plans - newser.com
Real time scanner hits for Ocular Therapeutix Inc. explained2025 Dividend Review & Community Consensus Trade Alerts - newser.com
Ocular Therapeutix (NASDAQ:OCUL) Price Target Raised to $20.00 - MarketBeat
Ocular Therapeutix (OCUL) Projected to Post Earnings on Tuesday - MarketBeat
How Ocular Therapeutix Inc. (0OT) stock behaves in tightening cyclesQuarterly Profit Report & Fast Entry Momentum Trade Alerts - newser.com
Why Ocular Therapeutix Inc. (0OT) stock is trending on social mediaWeekly Trend Summary & Technical Entry and Exit Alerts - newser.com
Is Ocular Therapeutix Inc. stock a buy in volatile marketsWeekly Profit Recap & Verified Technical Trade Signals - newser.com
Is this a good reentry point in Ocular Therapeutix Inc.Market Volume Summary & Long Hold Capital Preservation Tips - newser.com
Using Ichimoku Cloud for Ocular Therapeutix Inc. technicalsMarket Activity Recap & Free Weekly Chart Analysis and Trade Guides - newser.com
Detecting support and resistance levels for Ocular Therapeutix Inc.Layoff News & Verified Momentum Stock Alerts - newser.com
How Ocular Therapeutix Inc. (0OT) stock responds to job market shifts - newser.com
Finanzdaten der Ocular Therapeutix Inc-Aktie (OCUL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):